In 30 seconds
Evidence: In a 2019 crossover trial, 600mg/day of standardised ashwagandha extract was associated with a 14.7% greater testosterone rise over placebo across 16 weeks — trial evidence, not a claim about this product.
Timing: Total testosterone and cortisol both vary naturally with age, sleep quality and stress levels, day to day, not because of anything a supplement adds to that rhythm.
Next step: A baseline cortisol or testosterone test — via your GP or a UK service such as Medichecks — gives you your own numbers to track over time.
Ashwagandha (Withania somnifera) is a small evergreen shrub native to India and parts of North Africa, used for more than 3,000 years in Ayurvedic medicine as a rasayana — a rejuvenative tonic. Its primary mechanism is modulation of the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs your stress response and cortisol release, with secondary GABAergic activity that supports relaxation and sleep. In a 2019 placebo-controlled crossover trial of 43 overweight men aged 40–70, 600mg/day of standardised ashwagandha extract was associated with a 14.7% greater rise in testosterone versus placebo and a meaningful reduction in cortisol over 16 weeks (Lopresti et al., American Journal of Men's Health, 2019).
Ashwagandha has become one of the fastest-growing adaptogens in the UK supplement market post-pandemic, driven by rising demand for natural cortisol and stress support. The NHS does not formally endorse herbal adaptogens, but the European Medicines Agency (EMA) maintains a draft monograph recognising Withania somnifera root as a traditional herbal medicinal product for temporary stress and exhaustion. For UK men over 40, ashwagandha is one of the most-studied herbal options for cortisol management and general wellbeing. We cover the broader hormonal toolkit in our guide to Natural Testosterone Support: Complete Guide.
- Two standardised extracts dominate the evidence: KSM-66 (root only, ~5% withanolides) and Sensoril (root + leaf, ~10% withanolide glycosides — more sedating)
- In overweight men 40–70, total testosterone was 14.7% higher in the KSM-66 group versus placebo over 16 weeks (Lopresti 2019)
- Combined with resistance training, testosterone was 18.7% higher in the KSM-66 600mg/day group versus placebo, with 1.7kg of muscle gained versus 0.7kg, over 8 weeks (Wankhede 2015)
- In chronically stressed adults, full-spectrum root extract reduced serum cortisol by 27.9% over 60 days (Chandrasekhar 2012)
- In oligospermic (low sperm count) men, 675mg/day for 90 days raised sperm count by 167% (Ambiye 2013)
- Look for standardisation to 1.5–5% withanolides; avoid products that hide the percentage
What Is Ashwagandha and How Does It Work?
Ashwagandha (Withania somnifera) literally translates from Sanskrit as "the smell of horse" — a reference both to the root's distinctive odour and the traditional belief that it conferred the strength and vitality of a stallion. The plant is a small, woody perennial of the Solanaceae (nightshade) family, growing to about a metre tall in the dry, sub-tropical regions of India, Pakistan, and parts of North Africa. The medicinal part is the root, although some commercial extracts also use leaf material.
The primary bioactive compounds are withanolides, a class of naturally occurring steroidal lactones. The two most studied are withaferin A (concentrated heavily in the leaves) and withanolide D (more abundant in the root). Secondary actives include sitoindosides (which contribute to the antioxidant and anti-stress effects) and small amounts of withanine alkaloids.
Mechanistically, ashwagandha is best characterised as an HPA-axis modulator: it appears to dampen the cortisol response to chronic stress without flattening the natural cortisol rhythm needed for healthy energy and alertness. It also has well-documented GABAergic activity (calming, anxiolytic), modulates nitric-oxide synthase, and acts as a broad antioxidant. The cortisol effect is the most clinically important pathway for men — chronically elevated cortisol directly suppresses gonadotropin signalling and testosterone production.
Look for products standardised to 1.5–5% withanolides by weight. Two GMP-certified extracts dominate the published evidence:
- KSM-66® — manufactured by Ixoreal Biomed; full-spectrum root-only extract standardised to ≥5% withanolides via a proprietary green-chemistry water process. Used in the majority of testosterone, strength, and sleep RCTs.
- Sensoril® — manufactured by Natreon; root + leaf extract standardised to ≥10% withanolide glycosides. Higher withaferin-A content makes it more sedating — better suited to evening dosing.
A 2021 systematic review summarised the clinical landscape concisely: ashwagandha consistently lowers cortisol and stress-scale scores across heterogeneous study populations, with secondary benefits to sleep, testosterone, and male fertility appearing in well-designed RCTs (Smith et al., Advances in Nutrition, 2021). The cortisol effect is the most robust and reproducible — everything else follows from it.
What Are the Science-Backed Benefits of Ashwagandha for Men?
1. Cortisol Reduction & Stress Response
The cornerstone study is Chandrasekhar 2012: a 60-day double-blind, placebo-controlled trial of 64 chronically stressed adults given 300mg full-spectrum root extract twice daily. Serum cortisol fell by 27.9% in the ashwagandha group versus 7.9% in placebo (p=0.002), and all three validated stress scales — the Perceived Stress Scale (PSS), General Health Questionnaire (GHQ-28), and Depression Anxiety Stress Scale (DASS) — showed highly significant improvements (p<0.0001) (Chandrasekhar et al., Indian Journal of Psychological Medicine, 2012).
The Lopresti 2019 trial in overweight men 40–70 independently confirmed the cortisol effect at 600mg/day KSM-66, alongside the testosterone association. The pattern is consistent across nearly every well-designed RCT: in participants taking ashwagandha, cortisol was lower versus placebo, and lower cortisol is what creates the hormonal headroom for testosterone to recover.
2. Testosterone — Trial Evidence
The most cited testosterone study is Wankhede 2015: 57 men aged 18–50 were randomised to 600mg/day KSM-66 or placebo for 8 weeks alongside an identical resistance-training programme. In the ashwagandha group, total testosterone was 18.7% higher versus placebo, with larger gains in muscle mass at the arms (8.6cm² vs 5.3cm²) and chest, and significantly greater improvement in bench-press 1RM (Wankhede et al., JISSN, 2015).
In Lopresti 2019, testosterone was 14.7% higher in the ashwagandha group versus placebo (p=0.010), and DHEA-S was 18% higher (p=0.005), in overweight men aged 40–70. The pattern matches Tongkat Ali: the strongest effects appear in men whose testosterone is suppressed by stress, ageing, or excess body fat, not in athletes who already have optimal hormone levels.
Study Funding Transparency
Most positive ashwagandha RCTs — particularly those using KSM-66 — have been funded or supplied by the extract's manufacturer, Ixoreal Biomed. This is the same publication-funding pattern we see across most branded ingredient research, and it deserves an honest table:
| Study | Sample | Funding / Extract | Status |
|---|---|---|---|
| Lopresti 2019 (T + cortisol) | n=43, men 40–70 | Ixoreal Biomed (KSM-66 supplied) | Industry-supported |
| Wankhede 2015 (T + strength) | n=57, men 18–50 | Ixoreal Biomed (KSM-66 supplied) | Industry-supported |
| Chandrasekhar 2012 (cortisol) | n=64, stressed adults | Asha Hospital, India — no industry declared | Independent |
| Ambiye 2013 (fertility) | n=46, oligospermic men | Hospital-led, India | Independent |
| Langade 2019 / Salve 2019 (sleep) | n=60–80, insomnia | Ixoreal Biomed (KSM-66) | Industry-supported |
| Cheah 2021 (sleep meta-analysis) | 5 RCTs pooled | Academic review, no declared funding | Independent |
The honest summary: most of the strongest single studies are Ixoreal-funded, but the cortisol effect is replicated by the independent Chandrasekhar 2012 trial, the fertility effect by independent hospital-led Indian work, and the sleep effect by an independent meta-analysis. The directional consistency across funding sources is reassuring — even discounting industry trials, the cortisol-lowering mechanism is robust.
Editorial note — what this means in context: The cortisol-lowering mechanism is the most independently replicated finding in ashwagandha research. Ashwagandha's reported effects in trials are attributed to withanolide-driven HPA-axis dampening and GABAergic activity. No published RCT has tested it in combination with other supplements.
— Blue Power Research Team, reviewing Lopresti et al. (2019)3. Sleep Quality
A 2021 systematic review and meta-analysis pooling five RCTs (n≈400) confirmed that ashwagandha extract significantly improves overall sleep quality (SMD −0.59; 95% CI −0.75 to −0.42), with the strongest effects in adults with diagnosed insomnia at doses ≥600mg/day for ≥8 weeks (Cheah et al., PLoS One, 2021). The Salve/Langade 2019 RCT specifically showed improvements in sleep onset latency, sleep efficiency, and Pittsburgh Sleep Quality Index scores at 300mg twice daily for 10 weeks.
This matters more for men's hormones than it might first appear: roughly 70% of daily testosterone production happens during deep sleep. Just one week of restricted sleep (5 hours per night) can drop testosterone by 10–15% in healthy young men. Anything that reliably improves sleep quality therefore has an indirect but real effect on testosterone — which makes ashwagandha's sleep benefit a useful second mechanism on top of its direct HPA-axis effect.
4. Strength & Muscle Mass
In the Wankhede 2015 RCT, the resistance-trained ashwagandha group gained 1.7kg of lean muscle over 8 weeks versus 0.7kg for placebo, with significantly greater improvements in 1-rep-max bench press and leg-extension performance. The muscle-size gains at the arms (cross-sectional area increase of 8.6cm² vs 5.3cm² placebo) reached clinical significance. These effects appear to be downstream of the testosterone increase plus ashwagandha's antioxidant action on exercise-induced muscle damage markers.
5. Sperm Quality & Fertility
In Ambiye 2013, 46 oligospermic men (low sperm count) received 675mg/day root extract for 90 days. The results were striking: sperm count rose by 167% (from 9.59 to 25.61 million/mL), semen volume by 53%, and sperm motility by 57% — all p<0.0001 versus baseline (Ambiye et al., Evid Based Complement Alternat Med, 2013). An earlier study by Ahmad 2010 in 75 infertile men showed parallel improvements in sperm motility and count, with reduced oxidative stress markers in seminal fluid (Ahmad et al., Fertility & Sterility, 2010).
6. Anxiety
An early double-blind pilot in generalised anxiety disorder (GAD) by Andrade 2000 found a significant benefit on anxiety scales versus placebo (Andrade et al., Indian Journal of Psychiatry, 2000). The Chandrasekhar 2012 trial showed parallel improvements in the Depression-Anxiety-Stress Scale (DASS) alongside the cortisol drop. The effect is best characterised as "may reduce subjective stress and anxiety markers" rather than a clinical anxiolytic claim — ashwagandha is a food supplement, not a treatment for anxiety disorders.
Ashwagandha Forms, Extraction & Quality Standardisation
The ashwagandha shelf in any UK health-food shop is a maze of competing extract names, plant parts, and "high-strength" claims. Here is how the main forms compare on what actually matters — withanolide content, plant part, and clinical evidence:
| Form / Extract | Withanolide % | Origin (plant part) | Pros | Cons | Research / use notes |
|---|---|---|---|---|---|
| KSM-66® most-studied extract | ≥5% withanolides | Root only, water extraction | Most clinical trials; full-spectrum; non-sedating profile; well tolerated daytime | Mostly Ixoreal-funded studies | Most human RCTs; studied for daytime use |
| Sensoril® | ≥10% withanolide glycosides | Root + leaf | Higher active content per mg; strong stress + cognition data | Higher withaferin-A — more sedating; better for evening only | Studied at lower doses / evening use |
| Generic ashwagandha root powder | 1–3% (variable) | Root | Cheapest; whole-herb option | No standardisation guarantee; doses much higher (1–6g/day) | Variable standardisation; fewer matched RCTs |
| Standardised root extract (other brands) | 1.5–2.5% | Root | Often cheaper than KSM-66; transparent dose | Not the same extract used in clinical trials | Standardised to 1.5–2.5% withanolides; not the trial extract |
| Tinctures / liquid extracts | Rarely declared | Variable | Fast absorption; flexible dosing | Withanolide content almost never standardised; alcohol carrier | Withanolide content rarely declared; hard to match to RCT data |
How Much Ashwagandha Should Men Take? Clinical Dosage Guide
The clinical dose ranges depend heavily on which extract you choose, because withanolide concentration varies. The most commonly studied protocols in men:
- KSM-66 (root only, 5% withanolides): 600mg/day, typically split as 300mg twice daily (morning + early evening). This is the dose used in Wankhede 2015, Lopresti 2019, and the Salve/Langade 2019 sleep trial.
- Sensoril (root + leaf, 10% withanolide glycosides): 125–250mg/day, single dose. Lower because the higher withanolide concentration reaches a comparable systemic effect at less material.
- Generic root powder (1–3% withanolides): 3–6g/day to approximate clinical exposure — impractical for most users, but used in some traditional Ayurvedic protocols.
Time to effect: cortisol changes typically appear within 4–8 weeks of consistent dosing; testosterone improvements build over 8–12 weeks; sleep-quality benefits often show within 6 weeks. Cycling (taking breaks) is not required for most users, but a 1-week pause every 12 weeks is a reasonable conservative approach.
Are There Any Side Effects or Safety Concerns?
At clinical doses (300–1,250mg/day), ashwagandha is generally well-tolerated. The most commonly reported mild adverse events across RCTs are gastrointestinal upset, mild headache, and drowsiness — usually transient and dose-related (Raut et al., J Ayurveda Integr Med, 2012). However, the safety picture is more nuanced than the headline summary suggests, and there are several genuine cautions worth knowing.
- Autoimmune conditions (Hashimoto's, lupus, rheumatoid arthritis, multiple sclerosis) — ashwagandha may stimulate immune cell activity and worsen autoimmune flares
- Hyperthyroidism or thyroid medication — ashwagandha can raise T3/T4 levels; case reports document thyrotoxicosis in susceptible individuals (Sharma et al., 2018). Monitor TSH every 4–6 weeks if you are on levothyroxine
- Sedatives, benzodiazepines, or significant alcohol intake — additive sedative effect via shared GABAergic pathway
- Pregnancy — abortifacient potential at high doses; not recommended
- Hormone-sensitive conditions — given the testosterone- and DHEA-modulating effects
- Surgery — stop at least 2 weeks before scheduled procedures (potential blood-pressure and additional sedation effects with anaesthesia)
- Liver disease or abnormal liver function — the NIH LiverTox database lists rare case reports of cholestatic or mixed liver injury; the absolute risk appears low, but anyone with existing liver concerns should avoid ashwagandha and discuss with their GP if symptoms (fatigue, jaundice, dark urine) arise
Editorial note — the two cautions that matter most in the real world: Most ashwagandha users tolerate it without incident, but two warnings deserve more weight than they usually get in marketing copy. First, the thyroid effect is real — if you're on levothyroxine, ashwagandha can push you into a thyrotoxic state. Get TSH checked. Second, the autoimmune caveat is consistently underplayed — if you have Hashimoto's, lupus, RA, or MS, the immune-stimulating activity may worsen flares. These aren't theoretical risks; they're the most common reasons men come off ashwagandha in clinical practice.
— Blue Power Research Team, reviewing the NIH LiverTox monograph and Sharma 2018 thyroid case seriesHow to Choose Quality Ashwagandha in the UK
The UK ashwagandha market includes both standardised extracts and a long tail of generic powders with little quality control. Here is what separates a credible product from marketing noise:
- Named clinical extract: KSM-66 or Sensoril is on the label. If the product is anonymous "ashwagandha extract" with no brand or percentage, you cannot map it to the published evidence.
- Withanolide percentage declared: Look for at least 1.5–5% withanolides by weight. Any claim made without a percentage is unverifiable.
- GMP certification: UK or EU Good Manufacturing Practice ensures consistent batch quality. Look for a certificate or accredited manufacturing site.
- Third-party heavy-metal testing: Indian-grown botanicals have a documented historical risk of lead, arsenic, and mercury contamination. A current Certificate of Analysis (CoA) for heavy metals should be available on request.
- Dose transparency: Avoid proprietary blends that hide individual ingredient amounts. The label should state exactly how many milligrams of ashwagandha extract you get per serving.
How Blue Power Differs from Ashwagandha: Formula Disclosure
Honest Disclosure: Ashwagandha Is Not in Blue Power
Blue Power does not contain ashwagandha — this is a deliberate formulation choice, not an oversight. Ashwagandha is best taken as a single, clinically standardised extract at its full evidence-based dose (KSM-66 600mg/day); including it in a multi-ingredient tablet at a sub-clinical dose would not replicate the trial protocols.
Blue Power formula (one tablet per day, GMP-certified, UK-made):
Oat extract (Avena sativa) 10:1 50mg · Shilajit 50mg · Maca Root 50mg · Korean Ginseng 5:1 100mg · L-Arginine 50mg · Zinc 10mg (100% NRV) · Vitamin C 80mg.
Ashwagandha is not included.
Two of the formula's ingredients carry authorised EU/UK EFSA health claims relevant to men's health:
- Zinc contributes to the maintenance of normal testosterone levels in the blood.
- Zinc contributes to normal fertility and reproduction.
- Vitamin C contributes to the reduction of tiredness and fatigue.
- Vitamin C contributes to normal energy-yielding metabolism.
No other benefit claim is authorised for the Blue Power formula. Ashwagandha has no authorised EFSA health claim.
Blue Power is taken as one tablet daily in the morning with food. Ashwagandha (KSM-66 600mg/day, typically 300mg morning + 300mg early evening) is a separate supplement with its own dosing protocol. The two are different products with different ingredient profiles.
Blue Power: Oat extract (Avena sativa), Zinc, Shilajit & More — One Tablet Daily
Blue Power contains Oat extract (Avena sativa) 10:1 50mg, Shilajit 50mg, Maca Root 50mg, Korean Ginseng 5:1 100mg, L-Arginine 50mg, Zinc 10mg (100% NRV), and Vitamin C 80mg. GMP-certified, UK-made. Zinc contributes to the maintenance of normal testosterone levels in the blood.
Get Blue Power — Free UK DeliveryNo subscription required · 30-day supply · Free standard UK delivery
Reporting side effects. Food supplements are generally well tolerated, but if you notice an unexpected reaction to any supplement you can report it to the UK regulator through the MHRA Yellow Card Scheme. Always tell your GP or pharmacist about supplements you take, especially alongside prescription medicines.
Frequently Asked Questions About Ashwagandha for Men
What does ashwagandha do for men's testosterone?
The clinical evidence shows two consistent associations: in ashwagandha trial groups, cortisol was lower versus placebo (the stress hormone that suppresses testosterone), and testosterone was higher versus placebo. In overweight men aged 40–70, total testosterone was 14.7% higher in the KSM-66 600mg/day group versus placebo over 16 weeks (Lopresti et al., 2019). In resistance-training men 18–50, testosterone was 18.7% higher in the ashwagandha group versus placebo over 8 weeks (Wankhede et al., 2015). The strongest associations appear in men whose testosterone is suppressed by stress, ageing, or excess body fat.
Should men take ashwagandha in the morning or evening?
It depends on the extract. KSM-66 has a non-sedating profile and is typically split 300mg morning + 300mg early evening with food. Sensoril has higher withaferin-A from leaf material, which is more sedating — take it in the evening only, ideally 1–2 hours before bed. If you're new to ashwagandha, start with the morning dose to see how you respond before adding the second dose later in the day.
What is the difference between KSM-66 and Sensoril ashwagandha?
KSM-66 (made by Ixoreal) is a root-only extract standardised to ≥5% withanolides via a water-based process. It's the most clinically studied ashwagandha extract, with the largest body of testosterone, strength, sleep, and stress data, and is best for daytime use. Sensoril (made by Natreon) is a root + leaf extract standardised to ≥10% withanolide glycosides, with higher withaferin-A content. It's more sedating, used at lower doses (125–250mg/day), and best for evening use or stress/anxiety-focused goals.
Is it safe to take ashwagandha long-term?
Most clinical trials have been 8–16 weeks; the longest published safety study ran 12 months without significant adverse findings (Raut et al., 2012). However, the NIH LiverTox database lists rare case reports of cholestatic liver injury, and the UK FSA opened a call for evidence on ashwagandha safety in 2024. Men with liver disease, autoimmune conditions, hyperthyroidism, or those on thyroid medication, sedatives, or immunosuppressants should not take ashwagandha without GP advice.
Can ashwagandha be taken alongside a daily men's supplement?
No published RCT has tested ashwagandha in combination with other named supplements, so additive effects have not been studied. Ashwagandha is studied as a single standardised extract with its own dosing protocol (typically KSM-66 600mg/day). In Lopresti 2019, ashwagandha was associated with cortisol reduction and a 14.7% higher testosterone versus placebo. If you take any daily supplement, check the labels for overlap and consult a healthcare professional before combining products.
Does ashwagandha help with male fertility and sperm count?
Yes — the evidence in oligospermic (low sperm count) men is among the strongest in any natural fertility supplement. In Ambiye 2013, 675mg/day of root extract for 90 days increased sperm count by 167%, semen volume by 53%, and motility by 57% (all p<0.0001). The mechanism appears to be reduced oxidative stress in seminal fluid, with secondary effects from improved testosterone and cortisol balance. The data is strongest in men with already-impaired sperm parameters; effects in men with normal baseline fertility are smaller (Ambiye et al., 2013).
The Bottom Line: Is Ashwagandha Worth It for UK Men Over 40?
Ashwagandha sits in a relatively rare position for a herbal supplement: the cortisol-lowering effect is replicated across multiple independent studies (Chandrasekhar 2012 was hospital-led with no industry funding; the Cheah 2021 sleep meta-analysis was independent academic work), and the testosterone effect is supported by two well-designed RCTs in different populations. The honest caveat is that most testosterone-specific trials use KSM-66 supplied or funded by Ixoreal — the directional consistency with independent cortisol and fertility data is reassuring, but the funding pattern is worth knowing.
For a UK man over 40 dealing with chronic work stress, declining energy, and the gradual hormonal drift that comes with age, ashwagandha is one of the more evidence-supported natural options — particularly when stress and sleep quality are limiting factors. The strongest profile is exactly the demographic the supplement was designed around: not athletes with optimal hormones, but everyday men whose cortisol-testosterone balance has been worn down by life.
As a stand-alone supplement, KSM-66 600mg/day is the best-supported protocol, based on the trial populations described in this article. Blue Power is a separate food supplement with a distinct ingredient profile (Oat extract (Avena sativa), Shilajit, Zinc, and others); it does not contain ashwagandha. The two are different products studied in separate research programmes.
References & Sources (expand)
- Lopresti AL, Smith SJ, Malvi H, Kodgule R (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study in aging, overweight males. American Journal of Men's Health 13(2). PubMed 30787096
- Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition 12:43. PubMed 26609282
- Chandrasekhar K, Kapoor J, Anishetty S (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine 34(3):255–262. PubMed 23439798
- Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A (2013). Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha in oligospermic males. Evidence-Based Complementary & Alternative Medicine 2013:571420. PubMed 24371462
- Ahmad MK et al. (2010). Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertility and Sterility 94(3):989–996. PubMed 19501822
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R (2021). Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS ONE 16(9):e0257843. PubMed 34559859
- Smith SJ, Lopresti AL, Teo SYM, Fairchild TJ (2021). Examining the effects of herbs on testosterone concentrations in men: a systematic review. Advances in Nutrition 12(3):744–765. PubMed 33150931
- Sharma AK, Basu I, Singh S (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. Journal of Alternative & Complementary Medicine 24(3):243–248. PubMed 28829155
- Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R (2000). A double-blind, placebo-controlled evaluation of the anxiolytic efficacy of an ethanolic extract of Withania somnifera. Indian Journal of Psychiatry 42(3):295–301. PubMed 21407960
- Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, Pandey SN, Vaidya RA, Vaidya AB (2012). Exploratory study to evaluate tolerability, safety, and activity of ashwagandha (Withania somnifera) in healthy volunteers. Journal of Ayurveda & Integrative Medicine 3(3):111–114. PubMed 23329867
- European Medicines Agency. Withania somnifera (L.) Dunal — community herbal monograph (draft). EMA/HMPC. EMA monograph
- NHS UK. Vitamins, supplements and nutrition — general guidance. nhs.uk
- NIH LiverTox: Clinical and Research Information on Drug-Induced Liver Injury — Ashwagandha. NCBI LiverTox NBK548536
0 comments